Optimal Medical Therapy Improves Clinical Outcomes in Patients Undergoing Revascularization With Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting
Author(s) -
Javaid Iqbal,
YaoJun Zhang,
David R. Holmes,
MarieClaude Morice,
Michael J. Mack,
A. Pieter Kappetein,
Ted Feldman,
E Ståhle,
Javier Escaned,
Adrian Banning,
Julian Gunn,
Antonio Colombo,
Ewout W. Steyerberg,
Friedrich W. Mohr,
Patrick W. Serruys
Publication year - 2015
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.114.013042
Subject(s) - medicine , percutaneous coronary intervention , hazard ratio , cardiology , revascularization , myocardial infarction , coronary artery disease , clinical endpoint , randomized controlled trial , confidence interval , surgery
There is a paucity of data on the use of optimal medical therapy (OMT) in patients with complex coronary artery disease undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting (CABG) and its long-term prognostic significance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom